Rvr Labs Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 72.02%
(FY 2023)
- Profit 90.88%
(FY 2023)
- Ebitda 97.79%
(FY 2023)
- Net Worth 63.96%
(FY 2023)
- Total Assets -15.99%
(FY 2023)
About Rvr Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Bindu Uddaraju, Veerabhadra Gannabattula, Ranga Chilkuri, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24100TG2015PTC101522
- Company No.
101522
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Nov 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Rvr Labs Private Limited offer?
Rvr Labs Private Limited offers a wide range of products and services, including Organic Acid, API Intermediate, API Impurities, Chemical Compound, Industrial Chemicals & Supplies, Chemical Intermediates, Medical Laboratory Instruments, VTM Kit Raw Materials, Chemical Reagents & Catalysts, Organic Compounds.
Who are the key members and board of directors at Rvr Labs?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bindu Uddaraju  | Director | 04-Nov-2015 | Current |
| Veerabhadra Gannabattula | Director | 13-Feb-2024 | Current |
| Ranga Chilkuri | Director | 13-Feb-2024 | Current |
| Gandham Rao | Director | 20-Mar-2024 | Current |
| Surya Vegesna | Director | 04-Nov-2015 | Current |
Financial Performance of Rvr Labs.
Rvr Labs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 72.02% increase. The company also saw a substantial improvement in profitability, with a 90.88% increase in profit. The company's net worth Soared by an impressive increase of 63.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rvr Labs?
In 2023, Rvr Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sanux Laboratories Private LimitedActive 3 years 10 monthsGandham Rao and Surya Vegesna are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rvr Labs?
Unlock and access historical data on people associated with Rvr Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rvr Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rvr Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
